Login to Your Account

Second Acquisition This Month

GSK Buying Praecis For $55M, Gaining Cancer Drug, PPI-2458

By Jennifer Boggs

Friday, December 22, 2006
Continuing a late-year spending spree for biotech, GlaxoSmithKline plc is acquiring Praecis Pharmaceuticals Inc. in a cash deal valued at about $54.8 million. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription